The notation obsession exists because the supplement industry has conditioned consumers to believe that small differences in labeling signal meaningful differences in formulation
Although a HR below unity suggests a possible protective association, the absolute risk reduction was very small, and this finding should be considered tentative and hypothesis-generating
Follow local guidelines for medication disposal or consult your pharmacy for proper disposal instructions
The reality star shared a before-and-after photo and wrote, "the substantial amount of weight that I have lost really has made me feel and look younger than I have in a long time," in her caption
Robert Glatter, MD, an emergency physician at Lenox Hill Hospital in New York City and assistant professor at Zucker School of Medicine, told Healthline that these findings support the idea that some patients may have partial biologic resistance to incretin-based therapies. He added that genetics explains only part of the treatment differences and that routine pharmacogenomic screening is not yet ready for widespread clinical use. The same article noted that this PAM research looked at bloodsugar control, not weight loss, and GLP1 drugs are typically prescribed at higher doses for obesity than for diabetes
4e and Supplementary Data 3), just as occurred in Gclc -sufficient MZB (Fig